Live News Categoriesequity

Stoke Therapeutics, Inc. (STOK) News

Track canonical SquawkNews coverage tagged to STOK, Stoke Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol STOK Asset equity Sector Markets 90 days 1 Last 31.28 Updated Jun 30, 2026, 12:10 PM UTC Open live news feed

L Stoke Therapeutics Completes Enrollment Of 162 Patients Into Phase 3 EMPEROR Study Of Zorevunersen; Co Plans To Initiate Rolling NDA Submiss Company plans to initiate a rolling U.S. NDA submission to the FDA in the first quarter of 2027— —Phase 3 data readout anticipated in the third quarter of 2027 to complete the rolling U.S. NDA submission in the second ha REGULATION | Jun 30, 2026, 12:10 PM UTC